- Home
- EDUC vs BRTX Comparison
EDUC vs BRTX Comparison
Compare EDUC & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDUC
- BRTX
- Stock Information
- Founded
- EDUC 1965
- BRTX 1997
- Country
- EDUC United States
- BRTX United States
- Employees
- EDUC N/A
- BRTX N/A
- Industry
- EDUC Consumer Specialties
- BRTX Managed Health Care
- Sector
- EDUC Consumer Discretionary
- BRTX Health Care
- Exchange
- EDUC Nasdaq
- BRTX Nasdaq
- Market Cap
- EDUC 11.4M
- BRTX 12.5M
- IPO Year
- EDUC N/A
- BRTX N/A
- Fundamental
- Price
- EDUC $1.11
- BRTX $1.63
- Analyst Decision
- EDUC
- BRTX
- Analyst Count
- EDUC 0
- BRTX 0
- Target Price
- EDUC N/A
- BRTX N/A
- AVG Volume (30 Days)
- EDUC 313.8K
- BRTX 94.5K
- Earning Date
- EDUC 10-09-2025
- BRTX 08-12-2025
- Dividend Yield
- EDUC N/A
- BRTX N/A
- EPS Growth
- EDUC N/A
- BRTX N/A
- EPS
- EDUC N/A
- BRTX N/A
- Revenue
- EDUC $31,304,000.00
- BRTX $605,200.00
- Revenue This Year
- EDUC N/A
- BRTX $232.67
- Revenue Next Year
- EDUC N/A
- BRTX $52.92
- P/E Ratio
- EDUC N/A
- BRTX N/A
- Revenue Growth
- EDUC N/A
- BRTX 247.62
- 52 Week Low
- EDUC $0.92
- BRTX $1.21
- 52 Week High
- EDUC $2.49
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- EDUC 42.35
- BRTX 52.74
- Support Level
- EDUC $1.08
- BRTX $1.51
- Resistance Level
- EDUC $1.18
- BRTX $1.89
- Average True Range (ATR)
- EDUC 0.08
- BRTX 0.09
- MACD
- EDUC 0.01
- BRTX 0.02
- Stochastic Oscillator
- EDUC 31.25
- BRTX 38.10
About EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.